The effect of fenfluramine on glucose tolerance, insulin, lipid and lipoprotein levels in patients with peripheral arterial disease
| Autor: | R. G. Newall, C. J. C. Kirk, B. P. Bliss |
|---|---|
| Rok vydání: | 1972 |
| Předmět: |
Male
medicine.medical_specialty Fenfluramine Lipoproteins Glyceride medicine.medical_treatment Carbohydrate metabolism chemistry.chemical_compound Internal medicine medicine Humans Insulin Vascular Diseases Aged chemistry.chemical_classification Glucose tolerance test medicine.diagnostic_test Cholesterol business.industry Fatty acid Articles General Medicine Glucose Tolerance Test Middle Aged Lipids Endocrinology chemistry Carbohydrate Metabolism lipids (amino acids peptides and proteins) business Lipoprotein medicine.drug |
| Zdroj: | Postgraduate Medical Journal. 48:409-413 |
| ISSN: | 1469-0756 0032-5473 |
| DOI: | 10.1136/pgmj.48.561.409 |
| Popis: | Summary An investigation has been undertaken to determine the effects of fenfluramine on glucose tolerance, insulin, fasting lipid and lipoprotein levels, in a series of twenty-five patients suffering from peripheral arterial disease. The results indicate that fenfluramine significantly improved glucose tolerance and that this was not the result of increased insulin production. Small but significant reduction in fasting cholesterol and β lipoprotein levels also occurred in most of the patients. Fenfluramine had no consistent effect on fasting nonesterified fatty acid, glycerides or pre-β lipoproteins. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|